Literature DB >> 7251062

Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.

M R Daha, L A Van Es.   

Abstract

The role of complement in the processing of soluble immune aggregates by guinea-pig peritoneal macrophages was studied in a homologous system in vitro. Stable soluble aggregates of guinea-pig IgG1 are shown to activate the alternative pathway in C4-deficient guinea-pig serum. At 37 degrees and under serum-free conditions, adherent peritoneal macrophages degraded in 2 hr at least 50% of the available immunoglobulin aggregates. Addition of fresh C4D serum to the incubation mixtures caused a two-fold increase in the rate of degradation. The stimulating effect of C4D serum was complement-mediated, because it was abolished by heat treatment, CoVF treatment and specific C3 depletion of the C4D serum. Functional inactivation of C3 receptors on the macrophages by trypsin also impeded the stimulating effect of fresh C4D serum. The results indicate that the alternative pathway of complement contributes significantly to the elimination of soluble immune complexes by mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251062      PMCID: PMC1555056     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  10 in total

1.  Characteristics of soluble immune complexes prepared from oligovalent DNP conjugates and anti-DNP antibodies.

Authors:  A Kijlstra; D W Knutson; A van der Lelij; L A van Es
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Activation of the alternate pathway of human complements by rabbit cells.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Two complement interaction sites in guinea pig immunoglobulins.

Authors:  A L Sandberg; B Oliveira; A G Osler
Journal:  J Immunol       Date:  1971-01       Impact factor: 5.422

4.  C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

5.  Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors.

Authors:  D M Segal; E Hurwitz
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

6.  Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement.

Authors:  A Kijlstra; L A Van Es; M R Daha
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

7.  The effect of lidocaine on the processing of soluble immune aggregates and immune complexes by peritoneal macrophages.

Authors:  A Hijlstra; W Van Dorp; M R Daha; G Q Leslie
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

8.  Mechanisms underlying binding of immune complexes to macrophages.

Authors:  J M Phillips-Quagliata; B B Levine; F Quagliata; J W Uhr
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

9.  The effect of complement on the ingestion of soluble antigen-antibody complexes and IgM aggregates by mouse peritoneal macrophages.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Association and dissociation of aggregated IgG from rat peritoneal macrophages.

Authors:  D W Knutson; A Kijlstra; L A Van Es
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

  10 in total
  10 in total

1.  Autoradiographical demonstration of C3b receptor activity on resident peritoneal macrophages.

Authors:  R de Water; L A Ginsel; W T Daems; M R Daha
Journal:  Histochemistry       Date:  1983

2.  Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.

Authors:  M R Daha; L A Van Es
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

3.  The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.

Authors:  M R Daha; L A van Es
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

4.  Functional deficiency of complement factor D in a monozygous twin.

Authors:  H C Kluin-Nelemans; H van Velzen-Blad; H P van Helden; M R Daha
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

5.  Effect of bacterial competition on the opsonization, phagocytosis, and intracellular killing of microorganisms by granulocytes.

Authors:  B A Dijkmans; P C Leijh; A G Braat; R van Furth
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Hereditary C6 deficiency in a strain of PVG/c rats.

Authors:  P L Leenaerts; R K Stad; B M Hall; B J Van Damme; Y Vanrenterghem; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

7.  Characteristics of anti-Legionella antibodies in patients infected with Legionella pneumophila serogroups 1, 6, and 10.

Authors:  T L van Zwet; P L Meenhorst; P C Leijh; M R Daha; R van Furth
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.

Authors:  M R Daha; R M Bertina; J Thompson; R H Kauffmann; A Nicholson-Weller; J J Veltkamp; E Briët
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Immunoglobulin deficiency with increased immunoglobulin M in three siblings: effect of long-term immunoglobulin therapy.

Authors:  L Maródi; I Szabó; A Kalmár
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

10.  Complete and partial deficiencies of complement factor D in a Dutch family.

Authors:  P S Hiemstra; E Langeler; B Compier; Y Keepers; P C Leijh; M T van den Barselaar; D Overbosch; M R Daha
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.